Magna declined to comment but a spokesman for the companysaid the board of the Canadian auto parts supplier had approvedmanagement’s

Magna declined to comment, but a spokesman for the companysaid the board of the Canadian auto parts supplier had approvedmanagement’s plans to submit an offer for Opel by the Europeanclose of business on Monday.(Reporting by Christiaan Hetzner and Angelika Gruber) Stocks Mergers & Acquisitions. Each individual company analysis includes:* A full four year financial assessment * Debt indicator * Latest sales/profitability rankings * Employee Performance Analysis * Comparisons against industry average * Overall company financial rating * Industry ranking matrix * Company SummaryFor more information visit http:// WoodSenior Fax from USA: 646-607-1907Fax from rest of the world: +353-1-481-1716 Copyright Business Wire 2009. This key information identifies;* Best trading partners (based on commercial and financial strength) * Sales growth (highest sales, growth rate, size of market, average growth) * Profitability (Profit return on assets, pre-tax profit margins, industryaverage) * Fastest growing companies (performance matrix)Companies can change at an alarming rate in a very short space of time, so it isvital that you keep up-to-date with any changes to your market, and how thosechanges can affect you. Using an industry estimate of $4,000 per kilowatt, the new reactorcould cost about $6.4 billion. The NRC renewed the plant’s original 40-year operating licenses in 2000for another 20 years until 2034 and 2036 – the first extensions granted toa commercial nuclear power plant Unit 2 continued to operate at full power One MW powers about 800 homes in Maryland.

Drug development involves a very high degree of risk.Success of a product candidate in early stage clinical trials or pre-clinicaltrials does not mean that subsequent trials will also be successful or that thecandidate will be successfully commercialized. In addition, any forward-looking statements representAlnylam`s views only as of today and should not be relied upon as representingits views as of any subsequent date. In addition, the Company,in collaboration with Alnylam Pharmaceuticals, Inc. The Cubistproduct pipeline includes ecallantide, a recombinant human protein in Phase 2clinical trials – CONSERV-1 and CONSERV-2 – for the reductionof blood lossduring cardiac surgery, and two Phase 1 programs that address unmet medicalneeds, one in CDAD (Clostridium difficile-associated diarrhea) and the other inmulti-drug resistant (MDR) Gram-negative infections.

is a biopharmaceutical company focused on theresearch, development, and commercialization of pharmaceutical products thataddress unmet medical needs in the acute care environment. RNAi is a natural process of gene silencing that occurs inorganisms ranging from plants to mammals. Gilman, Ph.D., Senior Vice President, Chief Scientific Officer,for Cubist Pharmaceuticals. “As such, these data provide important de-riskingfor the advancement of our overall ALN-RSV program.

(Reporting by Ajay Kamalakaran in Bangalore; Editing byMaureen Bavdek) Stocks Regulatory News IPOs Funds News ETFs News. AIG has already begun the process for an IPO of AmericanInternational Assurance Co Ltd (AIA) early next year, selectingMorgan Stanley and Deutsche Bank AG (DBKGn.DE) as globalcoordinators for the offering. The bank must get permission for expenses beyond $5million, according to the documents. Maggie HuangInvestor Relations ManagerPhone: +86-10-8518-5620Email: In the U.S.:Ms. Leslie Wolf-CreutzfeldtInvestor RelationsGraylingPhone: +1-646-284-9472Email: SOURCEFuwei Films (Holdings) Co Ltd.In China, Ms.

The Court sustained plaintiffs’ remaining claims.However, the Court notedthat the defendants may be able to assert affirmative defenses provided by thefederal securities laws in a motion for summary judgment, which could resolvethe case before trial.Now that the motions to dismiss have been ruled upon, the defendants mustsubmit responsive pleadings to the Complaint and discovery will proceed. There is considerable potential for Nujira`s technology, and weare pleased to help introduce it to the key global markets.” Nujira`s High Accuracy Tracking (HAT) technology modulates the voltage suppliedto the power amplifier (PA) in line with the transmission envelope, to ensurethat the output device remains in its most efficient operating region.Integrating the Nujira Coolteq power modulator into a PA will dramaticallyimprove power efficiency (typically from 15% to 45%). visit Coupons Patrick Crisp, Copyright Business Wire 2009. * The current political and energy landscape in Germany – a country whichdepends on coal for about half of its electricity needs – provides the idealplatform for the development of CCS. clients and licensees include the majority of top consumerpackaged goods companies such as Johnson & Johnson, General Mills,Kimberly-Clark, Kraft Foods, McDonalds and Clorox as well as hundreds of groceryretailers including Kroger, Safeway, CVS, Walgreens and Kmart. NujiraHigh Accuracy Tracking (HAT) Modulator technology dynamically controls the powersupply to the circuit in line with the transmission performance required,enabling the creation of highly efficient RF Power Amplifiers for 3G and 4Gcellular networks and DVB digital broadcast transmissions. van der Sluijs+opyright Business Wire 2009.

No Comments »

No comments yet.

RSS feed for comments on this post.

Leave a comment

You must be logged in to post a comment.